OCT imaging company Michelson Diagnostics closes $3.8M of $6.1M Series B financing

Multibeam optical coherence tomography (OCT) imaging system maker Michelson Diagnostics (Maidstone, Kent, England) has closed the $3.8 million (£2.5 million) first tranche of its Series B financing. This was led by global medical technology business Smith & Nephew (its strategic investor), and included new investor Kent County Council as well as existing investors.

Related: OCT developments address skin cancer diagnosis

The $3.3 million investment will be used to expand the company's commercial presence in Germany, launch its next-generation VivoSight OCT tissue imaging system, complete the ongoing U.S. multi-center clinical biopsy avoidance study, and explore further applications of the VivoSight system in areas such as wound care and dentistry. The company is also in discussions with other investors regarding the $2.3 million (£1.5 million) second tranche of its Series B financing, which is expected to close in the coming months.

The VivoSight point-of-care tissue imaging system noninvasively obtains images of the epidermis and superficial dermis of the skin for accurate, pain-free diagnosis in real time. The company's initial clinical application is for the diagnosis of non-melanoma skin cancer (NMSC), the most common form of skin cancer.

In March 2014, the company announced positive top line results from the successfully completed multi-center, prospective clinical trial in Germany for the diagnosis of basal cell carcinoma using the system at the American Academy of Dermatology's 72nd Annual Meeting (Denver, CO). Full results from the trial have been submitted for publication in a peer-reviewed journal. The trial demonstrated a statistically significant improvement in the specificity and Negative Predictive Value (NPV) of basal cell carcinoma diagnosis over both clinical and dermoscopy diagnosis.

VivoSight currently has regulatory clearance in Europe and Australia, and FDA clearance in the U.S.

Andrew Boyes, senior VP of strategic initiatives at Smith & Nephew, will join the company's Board. Together, they will collaborate to explore new indications for VivoSight, such as the investigation of burn depth assessment.


Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

OCT imaging improves percutaneous coronary intervention, study finds

OCT can visualize coronary arteries in patients undergoing percutaneous coronary intervention, leading to improved outcomes.

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS